These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38157863)

  • 1. EGFR-activated myofibroblasts promote metastasis of pancreatic cancer.
    Mucciolo G; Araos Henríquez J; Jihad M; Pinto Teles S; Manansala JS; Li W; Ashworth S; Lloyd EG; Cheng PSW; Luo W; Anand A; Sawle A; Piskorz A; Biffi G
    Cancer Cell; 2024 Jan; 42(1):101-118.e11. PubMed ID: 38157863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma.
    Biffi G; Oni TE; Spielman B; Hao Y; Elyada E; Park Y; Preall J; Tuveson DA
    Cancer Discov; 2019 Feb; 9(2):282-301. PubMed ID: 30366930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts barrier breaking via TGF-β blockade paved way for docetaxel micelles delivery to treat pancreatic cancer.
    Pang N; Yang Z; Zhang W; Du Y; Zhang L; Li X; Peng Y; Qi X
    Int J Pharm; 2024 Nov; 665():124706. PubMed ID: 39277152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer.
    Steele NG; Biffi G; Kemp SB; Zhang Y; Drouillard D; Syu L; Hao Y; Oni TE; Brosnan E; Elyada E; Doshi A; Hansma C; Espinoza C; Abbas A; The S; Irizarry-Negron V; Halbrook CJ; Franks NE; Hoffman MT; Brown K; Carpenter ES; Nwosu ZC; Johnson C; Lima F; Anderson MA; Park Y; Crawford HC; Lyssiotis CA; Frankel TL; Rao A; Bednar F; Dlugosz AA; Preall JB; Tuveson DA; Allen BL; Pasca di Magliano M
    Clin Cancer Res; 2021 Apr; 27(7):2023-2037. PubMed ID: 33495315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy.
    Yamashita K; Kumamoto Y
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell-Derived Cytokines.
    Schwörer S; Cimino FV; Ros M; Tsanov KM; Ng C; Lowe SW; Carmona-Fontaine C; Thompson CB
    Cancer Res; 2023 May; 83(10):1596-1610. PubMed ID: 36912618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer.
    Belle JI; Sen D; Baer JM; Liu X; Lander VE; Ye J; Sells BE; Knolhoff BL; Faiz A; Kang LI; Qian G; Fields RC; Ding L; Kim H; Provenzano PP; Stewart SA; DeNardo DG
    Cancer Discov; 2024 Jul; 14(7):1324-1355. PubMed ID: 38683144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.
    Neuzillet C; Nicolle R; Raffenne J; Tijeras-Raballand A; Brunel A; Astorgues-Xerri L; Vacher S; Arbateraz F; Fanjul M; Hilmi M; Samain R; Klein C; Perraud A; Rebours V; Mathonnet M; Bièche I; Kocher H; Cros J; Bousquet C
    J Pathol; 2022 Dec; 258(4):408-425. PubMed ID: 36102377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
    Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
    Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
    Awaji M; Saxena S; Wu L; Prajapati DR; Purohit A; Varney ML; Kumar S; Rachagani S; Ly QP; Jain M; Batra SK; Singh RK
    FASEB J; 2020 Jul; 34(7):9405-9418. PubMed ID: 32453916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells.
    Sempere LF; Gunn JR; Korc M
    Cancer Biol Ther; 2011 Aug; 12(3):198-207. PubMed ID: 21613822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer.
    McAndrews KM; Chen Y; Darpolor JK; Zheng X; Yang S; Carstens JL; Li B; Wang H; Miyake T; Correa de Sampaio P; Kirtley ML; Natale M; Wu CC; Sugimoto H; LeBleu VS; Kalluri R
    Cancer Discov; 2022 Jun; 12(6):1580-1597. PubMed ID: 35348629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15
    Dominguez CX; Müller S; Keerthivasan S; Koeppen H; Hung J; Gierke S; Breart B; Foreman O; Bainbridge TW; Castiglioni A; Senbabaoglu Y; Modrusan Z; Liang Y; Junttila MR; Klijn C; Bourgon R; Turley SJ
    Cancer Discov; 2020 Feb; 10(2):232-253. PubMed ID: 31699795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma.
    Alvarez MA; Freitas JP; Mazher Hussain S; Glazer ES
    J Gastrointest Cancer; 2019 Jun; 50(2):207-213. PubMed ID: 30891677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myofibroblastic cancer-associated fibroblast subtype heterogeneity in pancreatic cancer.
    Kearney JF; Trembath HE; Chan PS; Morrison AB; Xu Y; Luan CF; McCabe IC; Zarmer SA; Kim HJ; Peng XL; Yeh JJ
    J Surg Oncol; 2024 Apr; 129(5):860-868. PubMed ID: 38233984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
    Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
    J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
    J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice.
    Hedegger K; Algül H; Lesina M; Blutke A; Schmid RM; Schneider MR; Dahlhoff M
    Mol Oncol; 2020 Aug; 14(8):1653-1669. PubMed ID: 32335999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamine deficiency drives transforming growth factor-β signaling activation that gives rise to myofibroblastic carcinoma-associated fibroblasts.
    Mezawa Y; Wang T; Daigo Y; Takano A; Miyagi Y; Yokose T; Yamashita T; Yang L; Maruyama R; Seimiya H; Orimo A
    Cancer Sci; 2023 Nov; 114(11):4376-4387. PubMed ID: 37706357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting ErbB3-mediated stromal-epithelial interactions in pancreatic ductal adenocarcinoma.
    Liles JS; Arnoletti JP; Kossenkov AV; Mikhaylina A; Frost AR; Kulesza P; Heslin MJ; Frolov A
    Br J Cancer; 2011 Aug; 105(4):523-33. PubMed ID: 21792199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.